Skip to main content

Table 1 Gemcitabine and docetaxel in advanced osteosarcoma

From: Gemcitabine and docetaxel in relapsed and unresectable high-grade osteosarcoma and spindle cell sarcoma of bone

Drugs

Pts n.

RR

CR/PR

Authors

G 1,000 mg/m2

7

0 %

0/0

Merimsky O, Sarcoma 2000 [13]

G 675 mg/m2 D 75–100 mg/m2

10

30 %

0/3

Navid F, Cancer 2008 [14]

G 900 mg/m2 D 80–100 mg/m2

14

7 %

0/1

Fox E. SARC 003, Oncologist 2010 [15]

G 675 mg/m2 ± D 75–100 mg/m2

4

25 %

0/1

Gosiengfiao Y, J Pediatr Hematol Oncol 2012 [16]

G 675 mg/m2 + D 75–100 mg/m2

18

5 %

0/1

Qi WX, Jpn J Clin Oncol 2012 [17]

G 675–900 mg/m2 D 100 mg/m2

17

24 %

3/1

Song BS, Pediatr Blood Cancer 2014 [18]

  1. GD gemcitabine and docetaxel, RR response rate, CR complete response, PR partial response